Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vtex (VTEX) Cash & Equivalents (2020 - 2025)

Vtex's Cash & Equivalents history spans 6 years, with the latest figure at $15.7 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 15.69% year-over-year to $15.7 million; the TTM value through Dec 2025 reached $15.7 million, down 15.69%, while the annual FY2025 figure was $15.7 million, 15.69% down from the prior year.
  • Cash & Equivalents reached $15.7 million in Q4 2025 per VTEX's latest filing, down from $18.7 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $121.0 million in Q4 2021 to a low of $15.7 million in Q4 2025.
  • Average Cash & Equivalents over 5 years is $41.0 million, with a median of $24.4 million recorded in 2022.
  • Peak YoY movement for Cash & Equivalents: soared 106.65% in 2021, then tumbled 79.84% in 2022.
  • A 5-year view of Cash & Equivalents shows it stood at $121.0 million in 2021, then crashed by 79.84% to $24.4 million in 2022, then grew by 2.33% to $25.0 million in 2023, then fell by 25.19% to $18.7 million in 2024, then dropped by 15.69% to $15.7 million in 2025.
  • Per Business Quant, the three most recent readings for VTEX's Cash & Equivalents are $15.7 million (Q4 2025), $18.7 million (Q4 2024), and $25.0 million (Q4 2023).